Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.
Autorzy:
Tunbridge M; Central and Northern Adelaide Renal and Transplantation Service (CNARTS), The Royal Adelaide Hospital, Adelaide, South Australia, Australia. . Perkins GB; School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia.; SA Pathology, Adelaide, South Australia, Australia. Singer J; Department of Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Sydney, Australia.; Kidney Node, Charles Perkins Centre, University of Sydney, Sydney, Australia. Salehi T; Central and Northern Adelaide Renal and Transplantation Service (CNARTS), The Royal Adelaide Hospital, Adelaide, South Australia, Australia. Ying T; Department of Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Sydney, Australia.; Kidney Node, Charles Perkins Centre, University of Sydney, Sydney, Australia. Grubor-Bauk B; Discipline of Medicine, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.; Viral Immunology Group, Basil Hetzel Institute for Translational Research, Adelaide, South Australia, Australia. Barry S; Discipline of Medicine, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.; Molecular Immunology, Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.; Department of Paediatric Medicine, Women's and Children's Hospital, North Adelaide, South Australia, Australia. Sim B; Central and Northern Adelaide Renal and Transplantation Service (CNARTS), The Royal Adelaide Hospital, Adelaide, South Australia, Australia. Hissaria P; Department of Immunology, The Royal Adelaide Hospital, Adelaide, South Australia, Australia. Chadban SJ; Department of Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Sydney, Australia.; Kidney Node, Charles Perkins Centre, University of Sydney, Sydney, Australia. CoatesPT; Central and Northern Adelaide Renal and Transplantation Service (CNARTS), The Royal Adelaide Hospital, Adelaide, South Australia, Australia.; Discipline of Medicine, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
Pokaż więcej
Źródło:
Trials [Trials] 2022 Sep 15; Vol. 23 (1), pp. 780. Date of Electronic Publication: 2022 Sep 15.
Half a century of haemodialysis: two patient journeys.
Autorzy:
Pavlovic D; Polyclinic for Internal Medicine and Dialysis B. Braun Avitum, Zagreb, Croatia. Salehi T; Central Northern Adelaide Renal and Transplantation Service, Adelaide, Australia. Piccoli GB; Centre Hospitalier Le Mans, Le Mans, France. CoatesPT; Central Northern Adelaide Renal and Transplantation Service, Adelaide, Australia.
Pokaż więcej
Źródło:
Clinical kidney journal [Clin Kidney J] 2022 Apr 07; Vol. 15 (8), pp. 1622-1625. Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022).
Rapidly progressive metastatic adenocarcinoma of unknown primary 2 months following deceased donor renal transplantation-Donor- or recipient-derived?
Autorzy:
McMichael LC; Adelaide Medical School, University of Adelaide, Adelaide, South Australia.; Central Northern Adelaide Renal and Transplantation Service, Central Adelaide Local Health Network, Adelaide, South Australia. Carroll RP; Adelaide Medical School, University of Adelaide, Adelaide, South Australia.; Central Northern Adelaide Renal and Transplantation Service, Central Adelaide Local Health Network, Adelaide, South Australia. Rao NN; Adelaide Medical School, University of Adelaide, Adelaide, South Australia.; Central Northern Adelaide Renal and Transplantation Service, Central Adelaide Local Health Network, Adelaide, South Australia.; Lyell McEwin Hospital, Northern Adelaide Local Health Network, Adelaide, South Australia. CoatesPT; Adelaide Medical School, University of Adelaide, Adelaide, South Australia.; Central Northern Adelaide Renal and Transplantation Service, Central Adelaide Local Health Network, Adelaide, South Australia.
Pokaż więcej
Źródło:
Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2021 Feb; Vol. 26 (2), pp. 204. Date of Electronic Publication: 2020 Nov 09.
Rapamycin and abundant TCR stimulation are required for the generation of stable human induced regulatory T cells.
Autorzy:
Kim J; The Department of Molecular & Biomedical Science The School of Biological Sciences The Faculty of Sciences The University of Adelaide Adelaide SA Australia. Hope CM; Department of Gastroenterology Women's and Children's Hospital Adelaide SA Australia.; Molecular Immunology Group Robinson Research Institute School of Medicine The University of Adelaide Adelaide SA Australia. Perkins GB; The Department of Molecular & Biomedical Science The School of Biological Sciences The Faculty of Sciences The University of Adelaide Adelaide SA Australia. Stead SO; Discipline of Medicine School of Medicine The University of Adelaide Adelaide SA Australia.; College of Medicine and Public Health Discipline of Medicine Flinders University Bedford Park SA Australia. Scaffidi JC; Discipline of Medicine School of Medicine The University of Adelaide Adelaide SA Australia. Kette FD; Discipline of Medicine School of Medicine The University of Adelaide Adelaide SA Australia.; College of Medicine and Public Health Discipline of Medicine Flinders University Bedford Park SA Australia. Carroll RP; Discipline of Medicine School of Medicine The University of Adelaide Adelaide SA Australia.; Central Northern Adelaide Renal and Transplantation Service (CNARTS) The Royal Adelaide Hospital Adelaide SA Australia.; Division of Medical Sciences University of South Australia Adelaide SA Australia. Barry SC; Department of Gastroenterology Women's and Children's Hospital Adelaide SA Australia.; Molecular Immunology Group Robinson Research Institute School of Medicine The University of Adelaide Adelaide SA Australia. CoatesPT; Discipline of Medicine School of Medicine The University of Adelaide Adelaide SA Australia.; Central Northern Adelaide Renal and Transplantation Service (CNARTS) The Royal Adelaide Hospital Adelaide SA Australia.
Pokaż więcej
Źródło:
Clinical & translational immunology [Clin Transl Immunology] 2020 Dec 14; Vol. 9 (12), pp. e1223. Date of Electronic Publication: 2020 Dec 14 (Print Publication: 2020).
Baseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): The Australian cohort in a global aHUS registry.
Autorzy:
Soraru J; Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. Isbel N; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. Wong G; Centre for Transplant and Renal Research, Westmead Hospital, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.; School of Public Health, University of Sydney, Sydney, New South Wales, Australia. CoatesPT; Central and Northern Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.; Adelaide Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia. Mantha M; Department of Nephrology, Cairns Base Hospital, Cairns, Queensland, Australia. Abraham A; Department of Nephrology and Renal Transplant, Fiona Stanley Hospital, Perth, Western Australia, Australia. Juneja R; Flinders Medical Centre, Adelaide, South Australia, Australia. Hsu D; Department of Haematology, Liverpool Hospital, Sydney, New South Wales, Australia. Brown F; Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia. Bose B; Department of Nephrology, Nepean Hospital, Blue Mountains, New South Wales, Australia. Mudge D; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. Carroll R; Central and Northern Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Kausman J; Department of Nephrology and Renal Transplantation, The Royal Children's Hospital, Melbourne, Victoria, Australia. Hughes P; Department of Nephrology and Transplantation, The Royal Melbourne Hospital, Melbourne, Victoria, Australia. Barbour T; Department of Nephrology and Transplantation, The Royal Melbourne Hospital, Melbourne, Victoria, Australia. Durkan A; Department of Nephrology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia. Mount P; Department of Nephrology, Austin Health, Melbourne, Australia. Lee D; Department of Renal Medicine, Eastern Health Clinical School, Monash University Melbourne, Melbourne, Victoria, Australia. Larkins N; Department of Nephrology and Hypertension, Perth Children's Hospital, Perth, Western Australia, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia. Ranganathan D; Kidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, School of Medicine, Griffith University, Mount Gravatt, Queensland, Australia. Lim WH; Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
Pokaż więcej
Źródło:
Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2020 Sep; Vol. 25 (9), pp. 683-690. Date of Electronic Publication: 2020 May 31.
Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus.
Autorzy:
Clarke B; Department of Endocrinology and Metabolism Royal Adelaide Hospital Adelaide SA Australia.; Faculty of Health and Medical Sciences School of Medicine The University of Adelaide Adelaide SA Australia. Loudovaris T; St Vincents Institute Melbourne Vic. Australia. Radford T; Central Northern Adelaide Renal and Transplantation Service Royal Adelaide Hospital Adelaide SA Australia. Drogemuller C; Faculty of Health and Medical Sciences School of Medicine The University of Adelaide Adelaide SA Australia.; Central Northern Adelaide Renal and Transplantation Service Royal Adelaide Hospital Adelaide SA Australia. CoatesPT; Faculty of Health and Medical Sciences School of Medicine The University of Adelaide Adelaide SA Australia.; Central Northern Adelaide Renal and Transplantation Service Royal Adelaide Hospital Adelaide SA Australia. Torpy D; Department of Endocrinology and Metabolism Royal Adelaide Hospital Adelaide SA Australia.; Faculty of Health and Medical Sciences School of Medicine The University of Adelaide Adelaide SA Australia.
Pokaż więcej
Źródło:
Clinical case reports [Clin Case Rep] 2020 Aug 30; Vol. 8 (12), pp. 2759-2762. Date of Electronic Publication: 2020 Aug 30 (Print Publication: 2020).
An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy.
Autorzy:
Pavathuparambil Abdul Manaph N; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia. .; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, South Australia, 5000, Australia. .; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, 5000, Australia. .; Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar. . Sivanathan KN; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia.; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, South Australia, 5000, Australia.; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, 5000, Australia.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA. Nitschke J; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia.; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, 5000, Australia. Zhou XF; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, 5000, Australia. CoatesPT; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia.; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, 5000, Australia. Drogemuller CJ; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia.; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, 5000, Australia.
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2019 Sep 23; Vol. 10 (1), pp. 293. Date of Electronic Publication: 2019 Sep 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
Correction to: Urine-derived cells for human cell therapy.
Autorzy:
Manaph NPA; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, 5000, South Australia.; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, 5000, South Australia.; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, 5000, South Australia. Al-Hawwas M; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, 5000, South Australia. Bobrovskaya L; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, 5000, South Australia. CoatesPT; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, 5000, South Australia.; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, 5000, South Australia. Zhou XF; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, 5000, South Australia. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2018 Aug 22; Vol. 9 (1), pp. 222. Date of Electronic Publication: 2018 Aug 22.
Pavathuparambil Abdul Manaph N; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, 5000, South Australia.; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, 5000, South Australia.; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, 5000, South Australia. Al-Hawwas M; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, 5000, South Australia. Bobrovskaya L; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, 5000, South Australia. CoatesPT; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, 5000, South Australia.; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, 5000, South Australia. Zhou XF; School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, 5000, South Australia. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2018 Jul 11; Vol. 9 (1), pp. 189. Date of Electronic Publication: 2018 Jul 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
Transcriptome Profiling of IL-17A Preactivated Mesenchymal Stem Cells: A Comparative Study to Unmodified and IFN- γ Modified Mesenchymal Stem Cells.
Autorzy:
Sivanathan KN; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia; Centre for Clinical and Experimental Transplantation, Royal Adelaide Hospital, Adelaide, SA, Australia. Rojas-Canales D; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia; Centre for Clinical and Experimental Transplantation, Royal Adelaide Hospital, Adelaide, SA, Australia. Grey ST; Transplantation Immunology Group, Garvan Institute of Medical Research, Sydney, NSW, Australia. Gronthos S; South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Mesenchymal Stem Cell Laboratory, School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia. CoatesPT; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia; Centre for Clinical and Experimental Transplantation, Royal Adelaide Hospital, Adelaide, SA, Australia; Central Northern Adelaide Renal Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia.
Pokaż więcej
Źródło:
Stem cells international [Stem Cells Int] 2017; Vol. 2017, pp. 1025820. Date of Electronic Publication: 2017 Feb 15.
A Combinatorial Protein Microarray for Probing Materials Interaction with Pancreatic Islet Cell Populations.
Autorzy:
Delalat B; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Future Industries Institute, University of South Australia, Adelaide 5095 SA, Australia. . Rojas-Canales DM; School of Medicine, University of Adelaide, Adelaide5005 SA, Australia. .; Centre for Clinical and Experimental Transplantation, Adelaide 5000 SA, Australia. . Rasi Ghaemi S; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Future Industries Institute, University of South Australia, Adelaide 5095 SA, Australia. . Waibel M; Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy 3065 Vic, Australia. . Harding FJ; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Future Industries Institute, University of South Australia, Adelaide 5095 SA, Australia. . Penko D; School of Medicine, University of Adelaide, Adelaide5005 SA, Australia. .; Centre for Clinical and Experimental Transplantation, Adelaide 5000 SA, Australia. .; Central Northern Adelaide Renal Transplantation Service, Royal Adelaide Hospital, Adelaide 5000 SA, Australia. . Drogemuller CJ; School of Medicine, University of Adelaide, Adelaide5005 SA, Australia. .; Centre for Clinical and Experimental Transplantation, Adelaide 5000 SA, Australia. .; Central Northern Adelaide Renal Transplantation Service, Royal Adelaide Hospital, Adelaide 5000 SA, Australia. . Loudovaris T; Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy 3065 Vic, Australia. . CoatesPT; School of Medicine, University of Adelaide, Adelaide5005 SA, Australia. Toby.Coates@sa.gov.au.; Centre for Clinical and Experimental Transplantation, Adelaide 5000 SA, Australia. Toby.Coates@sa.gov.au.; Central Northern Adelaide Renal Transplantation Service, Royal Adelaide Hospital, Adelaide 5000 SA, Australia. Toby.Coates@sa.gov.au. Voelcker NH; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Future Industries Institute, University of South Australia, Adelaide 5095 SA, Australia. .
A Syntenic Cross Species Aneuploidy Genetic Screen Links RCAN1 Expression to β-Cell Mitochondrial Dysfunction in Type 2 Diabetes.
Autorzy:
Peiris H; Department of Human Physiology and Centre for Neuroscience, Flinders University, Adelaide, South Australia, Australia. Duffield MD; Department of Human Physiology and Centre for Neuroscience, Flinders University, Adelaide, South Australia, Australia. Fadista J; Lund University Diabetes Centre, Malmö, Sweden. Jessup CF; Islet Biology Laboratory, Department of Anatomy and Histology and Centre for Neuroscience, Flinders University, Adelaide, South Australia, Australia.; Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia. Kashmir V; Department of Human Physiology and Centre for Neuroscience, Flinders University, Adelaide, South Australia, Australia. Genders AJ; Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Australia. McGee SL; Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Australia.; Metabolism and Inflammation Program, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. Martin AM; Department of Human Physiology and Centre for Neuroscience, Flinders University, Adelaide, South Australia, Australia. Saiedi M; Department of Human Physiology and Centre for Neuroscience, Flinders University, Adelaide, South Australia, Australia. Morton N; Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom. Carter R; Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom. Cousin MA; Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom. Kokotos AC; Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom. Oskolkov N; Lund University Diabetes Centre, Malmö, Sweden. Volkov P; Lund University Diabetes Centre, Malmö, Sweden. Hough TA; Mary Lyon Centre Pathology, MRC Harwell, Harwell Oxford Science Park, Oxford, United Kingdom. Fisher EM; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom. Tybulewicz VL; Francis Crick Institute, Mill Hill, London, United Kingdom.; Department of Medicine, Imperial College London, London, United Kingdom. Busciglio J; Department of Neurobiology and Behaviour, University of California, Irvine, Irvine, California, United States of America. Coskun PE; Department of Neurobiology and Behaviour, University of California, Irvine, Irvine, California, United States of America. Becker A; Department of Neurosciences School of Medicine, University of California, San Diego, San Diego, California, United States of America. Belichenko PV; Department of Neurosciences School of Medicine, University of California, San Diego, San Diego, California, United States of America. Mobley WC; Department of Neurosciences School of Medicine, University of California, San Diego, San Diego, California, United States of America. Ryan MT; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia. Chan JY; Diabetes and Metabolism Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales, Australia. Laybutt DR; Diabetes and Metabolism Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales, Australia. CoatesPT; Clinical and Experimental Transplantation Group, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia. Yang S; Animal Experiment Center, Animal Biosafety Level-III Laboratory, Wuhan University, Wuhan, China. Ling C; Lund University Diabetes Centre, Malmö, Sweden. Groop L; Lund University Diabetes Centre, Malmö, Sweden. Pritchard MA; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia. Keating DJ; Department of Human Physiology and Centre for Neuroscience, Flinders University, Adelaide, South Australia, Australia.; South Australian Health and Medical Research Institute, Adelaide, Australia.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2016 May 19; Vol. 12 (5), pp. e1006033. Date of Electronic Publication: 2016 May 19 (Print Publication: 2016).
Prevalence of Hypercalcaemia in a Renal Transplant Population: A Single Centre Study.
Autorzy:
Amin T; Central Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital, Adelaide, SA 5000, Australia. CoatesPT; Central Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital, Adelaide, SA 5000, Australia. Barbara J; Central Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital, Adelaide, SA 5000, Australia. Hakendorf P; Central Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital, Adelaide, SA 5000, Australia. Karim N; Central Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.
C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.
Autorzy:
Fuss A; The Centre for Clinical and Experimental Transplantation (CCET), Central Northern Adelaide Renal and Transplantation Services (CNARTS), Adelaide, South Australia, Australia.; Department of Medicine, The University of Adelaide, Adelaide, South Australia, Australia. Hope CM; The Centre for Clinical and Experimental Transplantation (CCET), Central Northern Adelaide Renal and Transplantation Services (CNARTS), Adelaide, South Australia, Australia.; Department of Medicine, The University of Adelaide, Adelaide, South Australia, Australia. Deayton S; Adelaide Division, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia. Bennett GD; Adelaide Division, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia. Holdsworth R; Adelaide Division, Australian Red Cross Blood Service (ARCBS), Adelaide, South Australia, Australia. Carroll RP; The Centre for Clinical and Experimental Transplantation (CCET), Central Northern Adelaide Renal and Transplantation Services (CNARTS), Adelaide, South Australia, Australia.; Department of Medicine, The University of Adelaide, Adelaide, South Australia, Australia. CoatesPT; The Centre for Clinical and Experimental Transplantation (CCET), Central Northern Adelaide Renal and Transplantation Services (CNARTS), Adelaide, South Australia, Australia.; Department of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.
Spontaneous glomerular mesangial lesions in common marmoset monkeys (Callithrix jacchus): a benign non-progressive glomerulopathy.
Autorzy:
Collins MG; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia; Transplant Immunology Laboratory, Basil Hetzel Institute for Medical Research, The Queen Elizabeth Hospital, Woodville, SA, Australia; School of Medicine, University of Adelaide, Adelaide, SA, Australia. Rogers NM Jesudason S Kireta S Brealey J CoatesPT
Pokaż więcej
Źródło:
Journal of medical primatology [J Med Primatol] 2014 Dec; Vol. 43 (6), pp. 477-87. Date of Electronic Publication: 2014 Jun 30.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies